GO:0004807 triose-phosphate isomerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004807 (triose-phosphate isomerase activity) catalyzes the reversible interconversion of D-glyceraldehyde 3-phosphate and dihydroxyacetone phosphate, a central step in glycolysis and gluconeogenesis.
• The enzyme is a highly conserved homodimer that uses a catalytic loop and a conserved glutamate residue to achieve near-diffusion-limited isomerization.
• Triose phosphate isomerase (TPI) is essential for efficient energy production and metabolic flux, and its dysfunction is linked to hemolytic anemia, neuromuscular disorders, and ischemic stroke pathology.
• In protozoan parasites such as Trypanosoma and Leishmania, TPI is a validated drug target, driving inhibitor discovery efforts [2,5,8].
• Plant TPI isoforms contribute to plastid metabolism and stress responses, as shown in tomato heat-response studies.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of TPI function in health and disease [1,6].
Description
Triose-phosphate isomerase activity (GO:0004807) is a fundamental enzymatic function that interconverts the two triose phosphates, D-glyceraldehyde 3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP). This reaction is a reversible aldose-ketose isomerization that sits at a key branch point in glycolysis and gluconeogenesis, ensuring that both triose phosphates can enter downstream energy-yielding or biosynthetic pathways. Because of its central metabolic role, TPI is conserved across all domains of life and has become a model system for understanding enzyme catalysis, protein evolution, and metabolic regulation [3,7]. Researchers study GO:0004807 not only to understand basic biochemistry but also to explore its contributions to human disease, including hemolytic anemia, neuromuscular dysfunction, and ischemic stroke. In protozoan parasites, TPI is a promising antiprotozoal target, and recent advances in inhibitor development highlight its therapeutic potential [2,5]. In plants, TPI isoforms are involved in plastid metabolism and heat stress responses, expanding the relevance of this GO term beyond medicine. This article integrates authoritative QuickGO data with verified PubMed literature to provide a research-grade overview of GO:0004807, covering its mechanism, key genes, disease associations, and modern experimental approaches including CRISPR-based models.
triose-phosphate isomerase activity At A Glance
| GO ID | GO:0004807 |
|---|---|
| GO term | triose-phosphate isomerase activity |
| Ontology | molecular_function |
| Synonym | D-glyceraldehyde-3-phosphate aldose-ketose-isomerase activity; D-glyceraldehyde-3-phosphate ketol-isomerase activity; phosphotriose isomerase activity; triosephosphate isomerase activity; triose phosphate mutase activity; triosephosphate mutase activity; triose phosphoisomerase activity |
| Major function | Catalyzes the reversible isomerization of D-glyceraldehyde 3-phosphate and dihydroxyacetone phosphate |
| EC number | 5.3.1.1 |
| Reaction direction | Reversible |
| Subcellular location | Cytoplasm, plastid (in plants), and possibly other compartments depending on isoform |
| Pathway context | Glycolysis, gluconeogenesis, Calvin cycle, and pentose phosphate pathway |
What Is GO:0004807?
According to the Gene Ontology, GO:0004807 (triose-phosphate isomerase activity) is defined as the catalysis of the reaction: D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate. In other words, it is the enzyme activity that reversibly converts the aldotriose phosphate G3P into the ketotriose phosphate DHAP. This isomerization is a classic example of an aldose-ketose isomerase reaction and is essential for balancing triose phosphate pools in central carbon metabolism [3,7].
Why Is triose-phosphate isomerase activity Important in Cell Biology?
Triose-phosphate isomerase activity is essential for efficient energy metabolism and metabolic homeostasis. By interconverting G3P and DHAP, it ensures that both triose phosphates can be funneled into glycolysis or gluconeogenesis, and it also supports the Calvin cycle in photosynthetic organisms [3,7]. Deficiencies or dysregulation of TPI can lead to metabolic imbalances, hemolytic anemia, and neuromuscular disorders, and recent evidence links TPI to microglial immunometabolism in ischemic stroke. In protozoan parasites, TPI is a validated drug target, and inhibitor development is an active area of research [2,5,8]. In plants, TPI isoforms contribute to plastid metabolism and heat stress responses, affecting crop resilience. Thus, understanding GO:0004807 has broad implications for human health, infectious disease, and agriculture.
• Central to glycolysis and gluconeogenesis, influencing ATP production and metabolic flux.
• Maintains triose phosphate balance for biosynthetic pathways such as lipid and nucleotide synthesis.
• Mutations in TPI can cause hemolytic anemia and neuromuscular dysfunction.
• TPI is a target for antiprotozoal drugs against Trypanosoma and Leishmania [2,5,8].
• In ischemic stroke, TPI1 remodels mitochondrial cristae to rewire microglial immunometabolism.
• Plant TPI isoforms are involved in heat stress responses and plastid metabolism.
• TPI interacts with cofilin to provide glycolytic fuel for Na,K-ATPase via Rho signaling.
• TPI is a model enzyme for studying catalytic perfection and protein engineering [3,7].
• CRISPR screens can identify TPI-dependent metabolic vulnerabilities in cancer and immune cells.
• TPI activity can be modulated by small-molecule inhibitors, offering therapeutic opportunities [2,5].
What Happens During triose-phosphate isomerase activity?
Substrate binding and isomerization
In simple terms: The enzyme grabs a sugar phosphate molecule and flips it into a different form.
Triose-phosphate isomerase binds D-glyceraldehyde 3-phosphate (G3P) in its active site, where a conserved glutamate residue abstracts a proton from the substrate, forming an enediol intermediate. This intermediate then collapses to yield dihydroxyacetone phosphate (DHAP). The reaction is reversible and proceeds with near-diffusion-limited kinetics, making TPI one of the most efficient enzymes known.
Catalytic loop and conformational changes
In simple terms: A flexible loop acts like a lid to close over the active site during catalysis.
The catalytic loop (residues 166-176 in many species) undergoes a conformational transition from an open to a closed state upon substrate binding, shielding the active site from solvent and facilitating proton transfer. Molecular dynamics simulations have revealed that this loop motion is coupled to the chemical step, and mutations that alter loop flexibility can reduce catalytic efficiency.
Dimerization and structural stability
In simple terms: Two identical protein subunits pair up to form the active enzyme.
TPI functions as a homodimer, with each subunit containing a complete active site. Dimerization is essential for stability and activity; monomeric forms are typically inactive or unstable. The dimer interface also contributes to allosteric regulation and cooperativity in some organisms.
Metabolic integration and flux control
In simple terms: The enzyme helps balance the flow of sugars through energy-producing pathways.
By interconverting G3P and DHAP, TPI ensures that both triose phosphates can enter glycolysis or gluconeogenesis. This is critical for maintaining flux through these pathways, especially when the demand for energy or biosynthetic precursors changes. In plants, plastid TPI isoforms are involved in the Calvin cycle and heat stress responses.
Key Genes Involved in GO:0004807 triose-phosphate isomerase activity
The following genes encode proteins that exhibit triose-phosphate isomerase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TPI1 | Encodes the canonical triose-phosphate isomerase in humans; catalyzes G3P-DHAP interconversion | Mutations cause TPI deficiency, hemolytic anemia, and neuromuscular disorders; linked to ischemic stroke |
| TPI2 | Plant plastid isoform of TPI | Involved in Calvin cycle and heat stress responses in tomato |
| TPI3 | Plant cytosolic isoform of TPI | Contributes to glycolysis and stress responses |
| TIM | Yeast triose-phosphate isomerase | Model enzyme for studying catalysis and protein stability [3,7] |
| Tpi | Trypanosoma brucei triose-phosphate isomerase | Drug target for African sleeping sickness [2,5] |
| TPI | Leishmania mexicana triose-phosphate isomerase | Validated target for antiprotozoal drugs |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Interacts with TPI in glycolytic metabolon |
| PFK1 | Phosphofructokinase 1 | Regulates glycolytic flux upstream of TPI |
| PKM | Pyruvate kinase | Downstream glycolytic enzyme; TPI activity affects pyruvate production |
| LDHA | Lactate dehydrogenase A | Couples with TPI in anaerobic glycolysis |
| COFILIN | Actin depolymerizing factor | Interacts with TPI to fuel Na,K-ATPase via Rho signaling |
| ATP1A1 | Na,K-ATPase alpha subunit | Receives glycolytic ATP from TPI-cofilin complex |
| RHOA | Rho GTPase | Mediates signaling between cofilin and TPI |
| HIF1A | Hypoxia-inducible factor 1 alpha | Regulates glycolytic genes including TPI under hypoxia |
| MYC | Oncogene | Drives glycolytic gene expression including TPI in cancer |
| TP53 | Tumor suppressor | Loss can alter glycolytic flux and TPI dependence |
| KEAP1 | Oxidative stress regulator | May influence TPI oxidation and activity |
| NRF2 | Antioxidant transcription factor | Regulates oxidative stress response affecting TPI |
How Is triose-phosphate isomerase activity Regulated?
Triose-phosphate isomerase activity is regulated at multiple levels. Transcriptionally, glycolytic genes including TPI1 are induced by hypoxia-inducible factor 1 (HIF1A) and oncogenes such as MYC, supporting increased glycolytic flux in cancer and immune cells. Post-translationally, TPI can undergo oxidation, phosphorylation, and acetylation, which may modulate its catalytic efficiency. In plants, TPI isoforms are regulated in response to heat stress, with differential expression of plastid and cytosolic isoforms. Additionally, TPI interacts with cofilin to form a complex that provides glycolytic ATP for Na,K-ATPase, linking its activity to Rho-mediated signaling. Small-molecule inhibitors can also directly modulate TPI activity, as pursued in antiprotozoal drug development [2,5].
triose-phosphate isomerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TPI1 | Hemolytic anemia, neuromuscular dysfunction | TPI1 knockout or point-mutation knock-in in hematopoietic stem cells or iPSCs |
| TPI1 | Ischemic stroke, microglial immunometabolism | Microglia-specific TPI1 knockout or overexpression in mouse stroke models |
| Tpi | Trypanosoma brucei infection | Parasite TPI knockout or inhibitor-treated cultures |
| TPI | Leishmania mexicana infection | Leishmania TPI knockout or overexpression in macrophages |
| TPI1 | Cancer metabolism | Cancer cell lines with TPI1 knockout or overexpression for metabolic profiling |
TPI deficiency and hemolytic anemia
Mutations in the TPI1 gene cause triose-phosphate isomerase deficiency, a rare autosomal recessive disorder characterized by chronic hemolytic anemia, neuromuscular dysfunction, and increased susceptibility to infections. The metabolic block leads to accumulation of DHAP, which is toxic to red blood cells and neurons. Research using patient-derived cells and animal models has elucidated the molecular basis of this disease, and CRISPR-based knockout models are valuable for studying the pathogenic mechanisms.
Ischemic stroke and microglial immunometabolism
Recent evidence indicates that TPI1 remodels mitochondrial cristae ultrastructure to rewire microglial immunometabolism against ischemic stroke. In this context, TPI1 supports the metabolic demands of activated microglia, and its manipulation can influence neuroinflammation and stroke outcomes. This highlights a novel role for GO:0004807 beyond classical glycolysis, linking it to immune cell function and brain injury.
Protozoan infections and drug targeting
Triose-phosphate isomerase is essential for glycolysis in protozoan parasites such as Trypanosoma brucei and Leishmania mexicana, making it an attractive drug target [2,8]. Inhibitors of TPI have shown trypanosomicidal activity, and recent efforts using artificial intelligence-based virtual screening have identified novel compounds with dual activity. These studies underscore the therapeutic potential of targeting GO:0004807 in infectious diseases [2,5].
Cancer metabolism and TPI
Many cancer cells rely on aerobic glycolysis (the Warburg effect), and TPI activity is often upregulated to support rapid proliferation. Targeting TPI or its regulatory network may selectively impair cancer cell metabolism. CRISPR screens have identified TPI as a potential metabolic vulnerability in certain cancer types, and small-molecule inhibitors are being explored [1,2].
From triose-phosphate isomerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of TPI1 loss on glycolysis and cell viability? | TPI1 knockout cell lines (e.g., HeLa, HEK293) generated by CRISPR |
| How do disease-associated TPI1 mutations affect enzyme activity? | Point-mutation knock-in of patient mutations in cell lines or iPSCs |
| Can TPI1 be targeted for antiprotozoal therapy? | Parasite TPI knockout or inhibitor screening in Trypanosoma cultures |
| What is the role of TPI1 in microglial immunometabolism? | Microglia-specific TPI1 knockout or overexpression in mouse models of stroke |
| How does TPI1 interact with cofilin and Na,K-ATPase? | Tagged knock-in of TPI1 (e.g., GFP) for co-immunoprecipitation and imaging |
| Does TPI1 overexpression enhance metabolic flux? | TPI1 overexpression in cancer or immune cells followed by metabolic assays |
How to Study the triose-phosphate isomerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Catalytic conversion of G3P to DHAP | Characterizing TPI mutants and inhibitors |
| X-ray crystallography | Three-dimensional structure of TPI | Understanding active site and loop dynamics |
| Molecular dynamics simulation | Conformational changes during catalysis | Elucidating reaction mechanism |
| CRISPR knockout screen | Genes required for cell fitness under TPI perturbation | Identifying synthetic lethal targets |
| Metabolomics | Levels of glycolytic intermediates | Assessing metabolic impact of TPI loss |
| 13C flux analysis | Flux through TPI and downstream pathways | Quantifying metabolic rewiring |
| Co-immunoprecipitation | Protein-protein interactions of TPI | Identifying TPI-cofilin complex |
| Live-cell imaging | Subcellular localization of tagged TPI | Studying mitochondrial cristae remodeling |
Enzyme activity assays
Triose-phosphate isomerase activity can be measured spectrophotometrically by coupling the isomerization of G3P to DHAP with glycerol-3-phosphate dehydrogenase and NADH oxidation. This assay is widely used to quantify TPI activity in cell lysates, purified protein preparations, and mutant variants. It is essential for characterizing the biochemical consequences of disease-associated mutations and for screening inhibitors [2,5].
Structural biology and molecular dynamics
X-ray crystallography and NMR spectroscopy have provided high-resolution structures of TPI from various organisms, revealing the active site architecture and catalytic loop conformations. Molecular dynamics simulations complement these structures by capturing the conformational transition and proton transfer events during catalysis. These methods are crucial for understanding the mechanism of GO:0004807 and for rational drug design.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that are synthetic lethal with TPI inhibition or that modulate TPI dependence in cancer cells. Such screens have revealed metabolic vulnerabilities and pathways that compensate for TPI loss. Similarly, CRISPR activation (CRISPRa) screens can identify genes whose overexpression rescues TPI deficiency.
Metabolic profiling and flux analysis
Metabolomics and stable isotope tracing (e.g., 13C-glucose labeling) are used to measure flux through TPI and its impact on downstream metabolites. These techniques quantify how TPI activity affects glycolysis, the pentose phosphate pathway, and biosynthetic pathways. They are particularly valuable in cancer and immune cell studies.
How CRISPR Can Be Used to Study GO:0004807 triose-phosphate isomerase activity
Knockout
CRISPR-Cas9 knockout of TPI1 or its orthologs is used to study the consequences of complete loss of triose-phosphate isomerase activity. TPI1 knockout cells typically exhibit impaired glycolysis, reduced ATP production, and accumulation of DHAP, leading to growth defects or lethality. In parasites, TPI knockout validates the enzyme as essential and aids drug target validation. In plants, knockout of specific TPI isoforms can reveal their roles in plastid metabolism and stress responses.
Point Mutation
Point mutations in TPI1 identified in patients with TPI deficiency can be introduced into cell lines or iPSCs using CRISPR prime editing or homology-directed repair. These models allow researchers to study how specific amino acid substitutions affect enzyme stability, catalytic efficiency, and cellular metabolism. For example, the Glu104Asp mutation is the most common cause of TPI deficiency, and knock-in models recapitulate the metabolic and hematological phenotypes.
Knock-in
Knock-in of tagged TPI1 (e.g., GFP, FLAG, or HA) enables visualization and biochemical isolation of the enzyme. Tagged knock-in models are valuable for studying TPI subcellular localization, interaction partners, and dynamics in live cells [1,6]. Additionally, knock-in of disease-associated mutations or regulatory elements can provide insights into TPI regulation and function.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of TPI1 is used to increase triose-phosphate isomerase activity above endogenous levels. Overexpression models help determine whether increased TPI activity enhances glycolytic flux, supports cell proliferation under stress, or protects against metabolic insults. In parasites, overexpression of TPI can be used to study inhibitor resistance mechanisms.
How EDITGENE Supports triose-phosphate isomerase activity Research
Researchers studying triose-phosphate isomerase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease pathogenesis, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of GO:0004807 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for triose-phosphate isomerase activity research.
Frequently Asked Questions About triose-phosphate isomerase activity
What is triose-phosphate isomerase activity?
Triose-phosphate isomerase activity (GO:0004807) is the enzyme activity that catalyzes the reversible interconversion of D-glyceraldehyde 3-phosphate and dihydroxyacetone phosphate, a key step in glycolysis and gluconeogenesis.
What genes are involved in triose-phosphate isomerase activity?
The primary gene is TPI1 in humans, which encodes the enzyme triose-phosphate isomerase. Other organisms have orthologs such as TPI in Trypanosoma and Leishmania, and TPI2/TPI3 in plants [1,4,8].
What diseases are associated with triose-phosphate isomerase deficiency?
TPI deficiency causes chronic hemolytic anemia, neuromuscular dysfunction, and increased infection susceptibility. It is also linked to ischemic stroke and cancer metabolism.
How is triose-phosphate isomerase activity measured?
It is typically measured using a coupled spectrophotometric assay that monitors NADH oxidation at 340 nm, reflecting the conversion of G3P to DHAP.
What is the role of TPI in glycolysis?
TPI ensures that both triose phosphates, G3P and DHAP, can proceed through glycolysis by interconverting them, thus maintaining flux and energy production.
Can triose-phosphate isomerase be targeted for drug development?
Yes, TPI is a validated drug target in protozoan parasites like Trypanosoma and Leishmania, and inhibitors are being developed as antiprotozoal agents [2,5].
What are the symptoms of TPI deficiency?
Symptoms include hemolytic anemia, jaundice, fatigue, muscle weakness, and neurological impairment. The severity varies depending on the mutation.
How do CRISPR models help study triose-phosphate isomerase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the precise roles of TPI in metabolism, disease, and drug response.
Is triose-phosphate isomerase conserved across species?
Yes, TPI is highly conserved from bacteria to humans, reflecting its essential role in central metabolism [3,7].
What is the catalytic mechanism of triose-phosphate isomerase?
The enzyme uses a conserved glutamate residue to abstract a proton from G3P, forming an enediol intermediate that collapses to DHAP. A flexible loop closes over the active site during catalysis.
Conclusion
Triose-phosphate isomerase activity (GO:0004807) is a cornerstone of cellular energy metabolism, catalyzing the reversible isomerization of G3P and DHAP. Its dysfunction is linked to hemolytic anemia, neuromuscular disorders, and ischemic stroke, while its essentiality in protozoan parasites makes it a prime drug target. Advances in CRISPR-based models and metabolic profiling continue to uncover new layers of TPI regulation and its roles in health and disease. EDITGENE's comprehensive services empower researchers to generate precise genetic models and accelerate discoveries related to this critical enzyme.
References
- 1. Zhang XW et al.. 2026. Triose phosphate isomerase 1 remodels mitochondrial cristae ultrastructure to rewire microglial immunometabolism against ischemic stroke.. Nat Commun 17(1) PMID: 42098112
- 2. Vázquez-Jiménez LK et al.. 2022. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents.. Curr Med Chem 29(14):2504-2529 PMID: 34517794
- 3. Leatherbarrow RJ et al.. 1986. Protein engineering.. Protein Eng 1(1):7-16 PMID: 3333843
- 4. Chen C et al.. 2024. Differential heat-response characteristics of two plastid isoforms of triose phosphate isomerase in tomato.. Plant Biotechnol J 22(3):650-661 PMID: 37878418
- 5. Aguilera E et al.. 2026. A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence-Based Virtual Screening.. ChemMedChem 21(8):e202500896 PMID: 42035276
- 6. Jung J et al.. 2002. Interaction of cofilin with triose-phosphate isomerase contributes glycolytic fuel for Na,K-ATPase via Rho-mediated signaling pathway.. J Biol Chem 277(50):48931-7 PMID: 12359716
- 7. Karplus M et al.. 1992. Simulation analysis of triose phosphate isomerase: conformational transition and catalysis.. Faraday Discuss PMID: 1290934
- 8. Kohl L et al.. 1994. Triose-phosphate isomerase of Leishmania mexicana mexicana. Cloning and characterization of the gene, overexpression in Escherichia coli and analysis of the protein.. Eur J Biochem 220(2):331-8 PMID: 8125090
